Literature DB >> 27464203

Treatment of Opioid-Use Disorders.

Marc A Schuckit1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27464203     DOI： 10.1056/NEJMra1604339

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  121 in total

1.  Cost-effectiveness of Direct Antiviral Agents for Hepatitis C Virus Infection and a Combined Intervention of Syringe Access and Medication-assisted Therapy for Opioid Use Disorders in an Injection Drug Use Population.

Authors:  Elizabeth R Stevens; Kimberly A Nucifora; Holly Hagan; Ashly E Jordan; Jennifer Uyei; Bilal Khan; Kirk Dombrowski; Don des Jarlais; R Scott Braithwaite
Journal:  Clin Infect Dis       Date:  2020-06-10       Impact factor: 9.079

Review 2.  Maternity Care for Pregnant Women with Opioid Use Disorder: A Review.

Authors:  Abigail H Rizk; Sara E Simonsen; Leissa Roberts; Lisa Taylor-Swanson; Jennifer Berkowicz Lemoine; Marcela Smid
Journal:  J Midwifery Womens Health       Date:  2019-08-12       Impact factor: 2.388

Review 3.  Neurotoxicology Syndromes Associated with Drugs of Abuse.

Authors:  Rachel A Caplan; Jonah P Zuflacht; Jed A Barash; Corey R Fehnel
Journal:  Neurol Clin       Date:  2020-11       Impact factor: 3.806

4.  Stigma and substance use disorders: A clinical, research, and advocacy agenda.

Authors:  Valerie A Earnshaw
Journal:  Am Psychol       Date:  2020-12

5.  Methadone Misinformation and Misconceptions.

Authors:  Lawrence S Brown; Steven Kritz
Journal:  Am J Public Health       Date:  2017-05       Impact factor: 9.308

Review 6.  Indications for Opioid Antagonists.

Authors:  O J Michael Coppes; Christine N Sang
Journal:  Curr Pain Headache Rep       Date:  2017-06

Review 7.  Extended-release injectable naltrexone for opioid use disorder: a systematic review.

Authors:  Brantley P Jarvis; August F Holtyn; Shrinidhi Subramaniam; D Andrew Tompkins; Emmanuel A Oga; George E Bigelow; Kenneth Silverman
Journal:  Addiction       Date:  2018-03-24       Impact factor: 6.526

8.  Buprenorphine Depresses Respiratory Variability in Obese Mice with Altered Leptin Signaling.

Authors:  Chelsea Angel; Zachary T Glovak; Wateen Alami; Sara Mihalko; Josh Price; Yandong Jiang; Helen A Baghdoyan; Ralph Lydic
Journal:  Anesthesiology       Date:  2018-05       Impact factor: 7.892

9.  Coercion into addiction treatment and subsequent substance use patterns among people who use illicit drugs in Vancouver, Canada.

Authors:  Andreas Pilarinos; Brittany Barker; Ekaterina Nosova; M-J Milloy; Kanna Hayashi; Evan Wood; Thomas Kerr; Kora DeBeck
Journal:  Addiction       Date:  2019-09-06       Impact factor: 6.526

10.  Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees.

Authors:  Hillary Samples; Arthur Robin Williams; Mark Olfson; Stephen Crystal
Journal:  J Subst Abuse Treat       Date:  2018-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.